33392

33392
Butt JH, Jhund PS, Belohlávek J, et al. Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation 2022; 146(16):1210–24. DOI: 10.1161/CIRCULATIONAHA.122.061754. http://www.ncbi.nlm.nih.gov/pubmed/36029465
Einstellungen
33392
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 29.11.2023 | 10:39 Uhr